Shareholding disclosure

Federated Hermes, Inc

Declared position

6.18%

Threshold

Crossed upwards

Timeline

Published

15.07.2020

Transaction

09.07.2020

Voting rights breakdown

Voting rights acquired6.18%

Voting rights sold0%

Below threshold0%

Notice details

CategoryCollective investment vehicle

ExchangeXSWX

Notification ID

TCK7E00013

Beneficial owner

Federated Hermes, Inc

Declared address

Federated Hermes, Inc., Pittsburgh PA

Aggregated holding (thereof Federated Kaufmann Fund holds 781,736 registered shares equal to 2.88%) of the voting rights in Molecular Partners AG. We herewith confirm that we meet and will continue to meet the independence requirements as stipulated in art. 18 para. 3 and 5 FMIO-FINMA.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Federated Hermes, Inc

Molecular Partners AG15.07.2020TCK7E00013

Disclosure summary

Federated Hermes, Inc disclosed a holding in Molecular Partners AG on the acquisition side, published by SIX Exchange Regulation on 15.07.2020, at 6.18% of voting rights. Notice category: Collective investment vehicle.

Disclosed position

6.18%

Voting rights acquired

Voting rights acquired6.18%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Federated Hermes, Inc disclosed a holding in Molecular Partners AG, published on 15.07.2020.

Publication date15.07.2020

Transaction date09.07.2020

Issuing companyMolecular Partners AG

Beneficial ownerFederated Hermes, Inc

Declared addressFederated Hermes, Inc., Pittsburgh PA

CategoryCollective investment vehicle

Voting rights acquired6.18%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTCK7E00013

Conditions

Aggregated holding (thereof Federated Kaufmann Fund holds 781,736 registered shares equal to 2.88%) of the voting rights in Molecular Partners AG. We herewith confirm that we meet and will continue to meet the independence requirements as stipulated in art. 18 para. 3 and 5 FMIO-FINMA.

Source: SIX Exchange Regulation · Publication date: 15.07.2020

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open